However, since the survey was conducted, an emerging marker, GPNMB, appears to show promise for recognizing renal neoplasms with MITF family translocations and TSC/MTOR pathway alterations [27, 28], which was not assessed in this study. The gene discussed is MITF; the disease is kidney neoplasm.